Jpmorgan Chase & CO AVADEL PHARMACEUTICALS PLC Transaction History

Jpmorgan Chase & CO

  • $1.51 Trillion
  • Q3 2025
Number of Shares
565,471
Previous 115,974 387.58%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
N/A
449,497 Added 387.58%
565,471 $0
Q1 2025

May 12, 2025
BUY
N/A
4,762 Added 4.28%
115,974 $0
Q4 2024

Feb 12, 2025
SELL
N/A
-3,813 Reduced 3.31%
111,212 $0
Q3 2024

Dec 26, 2024
BUY
N/A
2,259 Added 2.0%
115,025 $0
Q3 2024

Nov 08, 2024
BUY
N/A
2,259 Added 2.0%
115,025 $0
Q2 2024

Dec 26, 2024
SELL
N/A
-2,259 Reduced 1.96%
112,766 $0
Q2 2024

Aug 12, 2024
BUY
N/A
112,766 New
112,766 $0
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email